Literature DB >> 1842429

Evaluation of the xenodiagnosis of chronic Chagas patients infected ten years or over in an area where transmission has been interrupted--Iguatama and Pains, west Minas Gerais State, Brazil.

J R Coura1, L L de Abreu, H P Willcox, W Petana.   

Abstract

To evaluate the results of xenodiagnosis in chronic Chagas patients infected for ten years or over in an area where transmission has been stemmed as well as the performance of these tests applied one or more times to determine the presence of the parasite in serum-positive patients for Trypanosoma cruzi infection, 570 xenodiagnosis were performed in 246 patients by exposing each patient to 40 Triatoma infestans nymphs of 3rd/4th stage once, twice or three times, at 30 days intervals. The 570 xenodiagnosis showed overall positive results in 50.7% with a peak 78% in patients under 20 years of age, and 60.5% in those over 60. Of the 158 patients who underwent three xenodiagnosis, 51 (32.3%) had three positive tests, 48 (30.3%) had all negative results, and the remainder had alternating positive and negative findings. There was no difference in number of positive results between the 1st, 2nd and 3rd tests; however, the 1st and 2nd trials added up to 53.2% and the sum total of all three trials was 57.7%.

Entities:  

Mesh:

Year:  1991        PMID: 1842429     DOI: 10.1590/s0074-02761991000400003

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.

Authors:  Ana Maria de Castro; Alejandro Ostermayer Luquetti; Anis Rassi; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2006-03-29       Impact factor: 2.289

3.  Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.

Authors:  A L Basquiera; A Sembaj; A M Aguerri; M Omelianiuk; S Guzmán; J Moreno Barral; T F Caeiro; R J Madoery; O A Salomone
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Chagas cardiomyopathy in the context of the chronic disease transition.

Authors:  Alicia I Hidron; Robert H Gilman; Juan Justiniano; Anna J Blackstock; Carlos Lafuente; Walter Selum; Martiza Calderon; Manuela Verastegui; Lisbeth Ferrufino; Eduardo Valencia; Jeffrey A Tornheim; Seth O'Neal; Robert Comer; Gerson Galdos-Cardenas; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

5.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

6.  Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon.

Authors:  Rosa Amélia Gonçalves Santana; Laylah Kelre Costa Magalhães; Laise Kelman Costa Magalhães; Suzane Ribeiro Prestes; Marcel Gonçalves Maciel; George Allan Villarouco da Silva; Wuelton Marcelo Monteiro; Felipe Rocha de Brito; Leila Inês de Aguiar Raposo Câmara Coelho; João Marcos Barbosa-Ferreira; Jorge Augusto Oliveira Guerra; Henrique Silveira; Maria das Graças Vale Barbosa
Journal:  Parasit Vectors       Date:  2014-06-11       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.